Company news

Omniab, Inc. (NASDAQ:OABI) news

Omniab, Inc. news releases on 6ix. Latest, Aug 26, 2026: OmniAb to Participate in Upcoming Investor Conferences

View Omniab, Inc. →

Press releases & updates

OmniAb to Participate in Upcoming Investor Conferences

August 26, 2026

OmniAb Raises 2026 Financial Guidance

August 17, 2026

OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights

August 6, 2026

OmniAb to Report Second Quarter 2026 Financial Results on August 6

July 16, 2026

OmniAb Names Amechi Nwachuku Chief Operating Officer

July 13, 2026

OmniAb Reports First Quarter 2026 Financial Results and Business Highlights

May 7, 2026

OmniAb to Participate in Three Upcoming Investor Conferences

April 24, 2026

OmniAb to Report First Quarter 2026 Financial Results on May 7

April 21, 2026

OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

March 4, 2026

OmniAb to Participate at the Leerink Partners Global Healthcare Conference

February 24, 2026

OmniAb to Report Fourth Quarter 2025 Financial Results on March 4

February 19, 2026

Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

December 15, 2025

OmniAb to Hold OmniUltra Virtual Investor Event on December 15

December 4, 2025

OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors

November 17, 2025

OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

November 4, 2025

OmniAb to Participate in Three Investor Conferences in November

October 16, 2025

OmniAb to Report Third Quarter 2025 Financial Results on November 4

October 14, 2025

OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

September 2, 2025

OmniAb Announces $30 Million Private Placement

August 25, 2025

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

August 6, 2025

OmniAb to Report Second Quarter 2025 Financial Results on August 6

July 16, 2025

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

May 13, 2025

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

May 8, 2025

OmniAb Introduces the xPloration® Partner Access Program

May 8, 2025

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

May 5, 2025

OmniAb to Participate in Five Upcoming Investor Conferences

May 1, 2025

OmniAb Announces Two New Appointments to its Board of Directors

April 21, 2025

OmniAb to Report First Quarter 2025 Financial Results on May 8

April 14, 2025

OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

March 18, 2025

OmniAb to Report Fourth Quarter 2024 Financial Results on March 18

February 24, 2025

OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights

November 11, 2024

OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights

August 7, 2024

OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology

June 2, 2024

OmniAb Reports First Quarter 2024 Financial Results and Business Highlights

May 8, 2024

OmniAb to Report First Quarter 2024 Financial Results on May 9

April 21, 2024

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

March 19, 2024

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

February 25, 2024

OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights

November 8, 2023

OmniAb Appoints Steve Love to its Board of Directors

October 31, 2023

OmniAb Announces Agenda for its Research & Technology Virtual Event

October 30, 2023

OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights

August 9, 2023

OmniAb Announces the Passing of Director Sunil Patel

August 6, 2023

OmniAb to Report Second Quarter 2023 Financial Results on August 10

July 30, 2023

OmniAb Launches OmniDeep™ at the PEGS Boston Conference and Expo

May 16, 2023

OmniAb Reports First Quarter 2023 Financial Results and Business Highlights

May 10, 2023

OmniAb to Report First Quarter 2023 Financial Results on May 11

April 30, 2023

OmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

March 29, 2023

OmniAb to Report Fourth Quarter 2022 Financial Results on March 30

March 8, 2023

OmniAb Reports Third Quarter 2022 Financial Results and Business Highlights

November 14, 2022

OmniAb Business Combination Approved by APAC Shareholders

October 23, 2022